Adonis
AI orchestration platform for provider side revenue cycle, founded 2022 and built around the payer relationship rather than internal workflow alone. The company frames itself as an autonomous intelligence overlay rather than a replacement system of record, continuously monitoring aged accounts receivable, commercial denials, and shifting payer behaviour. Two product lines work together: Adonis Intelligence provides detection, alerting, denial clustering, smart worklists, and analytics, while AI Agents execute, navigating third party payer portals to run real time medical necessity and authorization checks, extracting unstructured clinical notes from the EHR to draft and file appeal letters, and progressing claims to resolution. Reported automation covers more than 70 percent of standard claim statusing and appeals tracking routines with a stated 20 to 30 percent reduction in long term revenue cycle operating spend. Available through the Epic Connection Hub. Mount Sinai Health System is a named customer using the platform to identify and prioritize billing exceptions, and Fox Valley Orthopedics reported recovering nearly $200,000 in denials. The company publishes an annual State of Revenue Cycle Management benchmark report, whose 2026 edition found payer denials and reimbursement pressure had overtaken staffing as the primary threat to revenue performance. More than $95 million raised including a $40 million Series C in March 2026; co-founder and CEO Akash Magoon.
Capability Axes
Detection and execution are both model driven: predicting which claims will be denied before submission from historical denial patterns and payer behaviour, clustering denials to find systemic causes, and then autonomously navigating payer portals, drafting appeal letters from unstructured clinical notes, and progressing claims. The company describes moving past descriptive analytics dashboards to a continuous loop of signal detection, prioritization, and agentic execution, which is the substantive difference from reporting tools in this category.
This is the most autonomous posture among the provider side revenue cycle vendors indexed here, and the disclosure does not match it. Agents are described as autonomously progressing claims to resolution, logging into payer portals, and drafting, packaging, and filing appeal letters, with more than 70 percent of standard claim statusing and appeals routines fully automated. An appeal letter is a formal representation to a payer assembled from a patient's clinical record, and no review step, confidence threshold, or escalation criterion was retrieved for the filing decision. The platform states appeals are auditable, which helps after the fact, but auditability is not oversight. Buyers should establish in contracting what is filed without human sign off.
Named references are strong for a company founded in 2022: Mount Sinai Health System uses the platform to identify and prioritize billing exceptions, with its system vice president of revenue cycle quoted directly, and Fox Valley Orthopedics reported recovering nearly $200,000 in denials. Commercial metrics are unusually concrete, with more than 4x revenue growth in 2025 and net retention above 130 percent, the latter being a genuine signal since it means existing customers expanded. Held back from A because the 20 to 30 percent operating spend reduction and 70 percent automation figures lack published baselines.
Positioned deliberately as an overlay rather than a replacement system of record, available through the Epic Connection Hub, and reaching in both directions: extracting unstructured clinical notes and charts from the EHR, and logging into third party payer portals to execute checks. Reaching into payer portals is the harder half, since those interfaces are outside the customer's control and change without notice.
No public pricing. Contact the vendor. Enterprise agreements with health systems and provider groups. The company publishes an annual State of Revenue Cycle Management benchmark report drawing on revenue cycle leaders across hospitals and provider groups, which is genuine market research rather than a product brochure, though buyers should read it as vendor sponsored research on a market the vendor sells into.
Clearly bounded to provider side revenue cycle with an explicit orientation toward payer dynamics: denials, underpayments, aged accounts receivable, prior authorization status, and appeals. The founder's stated background building technology for health insurers informs that positioning, which the company frames as levelling the playing field with payers.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Contact the vendor
|
Enterprise health system and provider group agreements | — | — | Vendor Published |
No rate card published. Enterprise agreements with health systems and provider groups. The stated value case is a 20 to 30 percent reduction in long term revenue cycle operating spend alongside recovered denial revenue, so the business case combines cost avoidance and revenue capture; buyers should separate the two, since recovered revenue is one time per claim while operating cost reduction is recurring. Establish also whether pricing is fixed, per claim, or tied to recoveries, given how autonomous the appeals filing is.